Polycyclic aromatic hydrocarbon-DNA adducts in humans: Relevance as biomarkers for exposure and cancer risk

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 215-231

  Kriek, Erik ^a   Rojas, Margarita ^b   Alexandrov, Kroum ^b   Bartsch, Helmut ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

32P postlabeling; Aromatic DNA adduct; Biomarker for cancer risk; Human exposure; Immunoassay; Polycyclic aromatic hydrocarbon; Smoking

Indexed keywords

BIOLOGICAL MARKER; CELL NUCLEUS DNA; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; MONOCLONAL ANTIBODY; PHOSPHORUS 32; POLYCLONAL ANTIBODY; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DNA ADDUCT; DNA DAMAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TOBACCO;

ANIMALS; BIOLOGICAL MARKERS; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; POLYCYCLIC HYDROCARBONS, AROMATIC; RISK ASSESSMENT;

EID: 0032565541     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00065-7     Document Type: Article

References (89)

1. [1] A. Manouvriez, Diseases and hygiene of workers making tar and pitch briquettes, Ann. Hyg. Publ. 45 (1876) 459-482.
2. [2] J.W. Cook, C.L. Hewett, I. Hieger, The isolation of a cancer-producing hydrocarbon from coal tar, J. Chem. Soc. (1933) 395-405.
3. [3] J.W. Cook, I. Hieger, E.L. Kenneway, W.V. Maynord, The production of cancer by pure hydrocarbons: I, Proc. R. Soc. London, Ser. B 0 (1932) 455-484.
4. [4] D.H. Phillips, Fifty years of benzo[a]pyrene, Nature 303 (1983) 468-472.
5. [5] P. Brookes, P.D. Lawley, Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power and their binding to deoxyribonucleic acid, Nature 202 (1964) 781-784.
6. [6] E.C. Miller, J.A. Miller, Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules, Cancer 47 (1981) 2327-2345.
7. [7] E. Boyland, The biological significance of metabolism of polycyclic compounds, Biochem. Soc. Symp. 5 (1950) 40-54.
8. [8] P.L. Graver, P. Sims, Enzyme-catalyzed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro, Biochem. J. 110 (1968) 159-160.
9. [9] H.V. Gelboin, A microsome-dependent binding of benzo[a]pyrene to DNA, Cancer Res. 29 (1969) 1272-1276.
10. [10] A. Borgen, H. Darvey, N. Castagnoli, T.T. Crocker, R.E. Rasmussen, I.Y. Wang, Metabolic conversion of benzo[a]pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid, J. Med. Chem. 16 (1973) 502-506.
11. [11] P. Sims, P.L. Graver, A. Swaisland, K. Pal, A. Hewer, Metabolic activation of benzo[a]pyrene proceeds by a diolepoxide, Nature 252 (1974) 326-328.
12. [12] P. Sims, P.L. Graver, Epoxides in polycyclic aromatic hydrocarbon carcinogenesis, Adv. Cancer Res. 20 (1974) 165-274.
13. [13] M.R. Osborne, F.A. Beland, R.G. Harvey, P. Brookes, The reaction of (±)-7,8 β-dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene with DNA, Int. J. Cancer 18 (1976) 362-368.
14. [14] A.M. Jeffrey, K.W. Jennette, S.H. Blobstein, I.B. Weinstein, F.A. Beland, R.G. Harvey, H. Kasai, I. Miura, K. Nakanishi, Structure of guanosine adducts formed by reaction with a tetrahydrodiol epoxide of benzo[a]pyrene, J. Am. Chem. Soc. 98 (1976) 5714-5715.
15. [15] M.F. Denissenko, A. Pao, M. Tang, G.P. Pfeifer, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p35, Science 274 (1996) 430-432.
16. [16] International Agency for Research on Cancer, Tobacco Smoking, Lyon, France, IARC Monogr., 38, 1986.
17. [17] H. Bartsch, E. Hietanen, The role of individual susceptibility in cancer burden related to environmental exposure, Environ. Health Perspect. 104 (1996) 569-577.
18. 32P-postlabelling analysis of non-radioactive aromatic carcinogen-DNA adducts, Carcinogenesis 3 (1982) 1081-1092.
19. 32P-postlabelling assay, Carcinogenesis 13 (1992) 1053-1974.
20. 32P-postlabelling methods for DNA adduct detection: overview and critical evaluation, Drug Metab. Rev. 26 (1994) 67-85.
21. 32P-postlabelling assay, Mutation Res. 378 (1997) 1-12.
22. 32P-postlabelling, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, International Agency for Research on Cancer, Lyon, IARC Sci. Publ., 124 (1993) 35-49.
23. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans, J. Chromatogr. Biomed. Appl. 580 (1992) 293-323.
24. 32P-postlabelled DNA adducts, Carcinogenesis 14 (1993) 1343-1348.
25. 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study, Mutation Res. 378 (1997) 41-50.
26. [26] M.C. Poirier, S.H. Yuspa, I.B. Weinstein, S. Blobstein, Detection of carcinogen-DNA adducts by radioimmunoassay, Nature 270 (1977) 186-188.
27. [27] M.C. Poirier, Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples, Mutation Res. 288 (1993) 31-38.
28. [28] M.C. Poirier, Human exposure monitoring, dosimetry and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA, Drug Metab. Rev. 26 (1994) 87-109.
29. [29] J.L. Mumford, K. Williams, T.C. Wilcosky, R.B. Everson, T.L. Young, R.M. Santella, A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues, Mutation Res. 359 (1996) 171-177.
30. [30] B. Schoket, W.A. Doty, I. Vincze, P.T. Strickland, G. Assennato, M.C. Poirier, Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA), Cancer Epidemiol. Biomarkers Prev. 2 (1993) 349-353.
31. [31] L. den Engelse, J. van Benthem, E. Scherer, Immunocytochemical analysis of in vivo DNA modifications, Mutation Res. 233 (1990) 265-287.
32. [32] K. Vähäkangas, A. Haugen, C.C. Harris, An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene diolepoxide-DNA adducts, Carcinogenesis 6 (1985) 1109-1116.
33. [33] K. Alexandrov, M. Rojas, O. Geneste, M. Castegnaro, A. Camus, S. Petruzzelli, C. Giuntini, H. Bartsch, An improved fluorometric assay for dosimetry of benzo[a]pyrene diolepoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity, Cancer Res. 52 (1992) 6248-6253.
34. 32P-postlabelling and ELISA, Carcinogenesis 15 (1994) 557-560.
35. [35] P.G. Shields, E.D. Bowman, A.M. Harrington, V.T. Doan, A. Weston, Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes, Cancer Res. 53 (1993) 3486-3492.
36. [36] F.P. Perera, D.L. Tang, J.P. O'Neill, W.L. Bigbee, R.J. Albertini, R. Santella, R. Ottman, W.Y. Tsai, C. Dickey, L.A. Mooney, K. Savela, K. Hemminki, HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts, Carcinogenesis 14 (1993) 969-973.
37. [37] F.P. Perera, C. Dickey, R. Santella, J.P. O'Neill, R.J. Albertini, R. Ottman, W.Y. Tsai, L.A. Mooney, K. Savela, K. Hemminki, Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons, Carcinogenesis 15 (1994) 2905-2910.
38. 32P-postlabelling and enzyme-linked immunosorbent assay, Environ. Health Perspect. 99 (1993) 307-309.
39. [39] F.J. Van Schooten, F.E. van Leeuwen, M.J.X. Hillebrand, M.E. de Rijke, A.A.M. Hart, H.G. van Veen, S. Oosterink, E. Kriek, Determination of benzo[a]pyrene diolepoxide-DNA adducts in lymphocyte DNA from coke oven workers with polyclonal antibodies: the impact of smoking, J. Natl. Cancer Inst. 82 (1990) 927-933.
40. [40] G. Assennato, G.M. Ferri, V. Foà, P. Strickland, M. Poirier, L. Pozzoli, D. Cottica, Correlation between PAH airborne concentration and PAH-DNA adduct levels in coke oven workers, Int. Arch. Occup. Environ. Health 65 (1993) S143-S145.
41. [41] N. Rothman, A. Correa-Villasenor, D.P. Ford, M.C. Poirier, R. Haas, J.A. Hansen, T. O'Toole, P.T. Strickland, Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters, Cancer Epidemiol. Biomarkers Prev. 2 (1993) 341-348.
42. [42] K. Hemminki, C. Dickey, S. Karlsson, D. Bell, Y.-Z. Hsu, W.Y. Tsai, L.A. Mooney, K. Savela, F.P. Perera, Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype, Carcinogenesis 18 (1997) 345-350.
43. [43] F.J. Van Schooten, F.J. Jongeneelen, M.J.X. Hillebrand, F.E. van Leeuwen, A.J.A. de Looff, A.P.G. Dijkmans, J.G.M. van Rooij, L. den Engelse, E. Kriek, Polycyclic aromatic hydrocarbon-DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 69-77.
44. [44] M. Rojas, K. Alexandrov, G. Auburtin, A. Wastiaux-Denamur, L. Mayer, B. Mahieu, P. Sebastien, H. Bartsch, Anti-benzo[a]pyrene diolepoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking, Carcinogenesis 16 (1995) 1373-1376.
45. [45] W. Popp, C. Vahrenholz, C. Schell, R. Kraus, J. von Bülow, G. Müller, K. Norpoth, Risk estimation in coke oven workers by determining some biomarkers of carcinogen exposure, Exp. Toxicol. Pathol. 47 (1995) 440-442.
46. [46] D.H. Kang, N. Rothman, M.C. Poirier, A. Greenberg, C.H. Hsu, B.S. Schwartz, M.E. Baser, J.D. Groopman, A. Weston, P.T. Strickland, Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after char-broiled beef consumption, Carcinogenesis 16 (1995) 1079-1085.
47. [47] M.C. Poirier, R.M. Santella, I.B. Weinstein, D. Grunberger, S.H. Yuspa, Quantitation of benzo[a]pyrene-deoxyguanosine adducts by radioimmunoassay, Cancer Res. 40 (1980) 412-416.
48. [48] G. Motykiewicz, E. Malusecka, E. Grzybowska, M. Chorazy, Y.-J. Zhang, F.P. Perera, R.M. Santella, Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes, Cancer Res. 55 (1995) 1417-1422.
49. [49] F.P. Perera, K. Hemminki, E. Grzybowska, G. Motykiewicz, J. Michalska, R.M. Santella, T.-L. Young, C. Dickey, P. Brandt-Rauf, I. De Vivo, W. Blaner, W.Y. Tsai, M. Chorazy, Molecular and genetic damage in humans from environmental pollution in Poland, Nature 360 (1992) 256-258.
50. 32P-HPLC, Carcinogenesis 17 (1996) 61-66.
51. [51] B. Binková, J. Lewtas, I. Mišková, P. Rössner, M. Cerná, G. Mrácková, K. Peterková, J. Mumford, S. Meyer, R. Šrám, Biomarker studies in northern Bohemia, Environ. Health Perspect. 104 (1996) 591-597.
52. [52] P.S. Nielsen, N. de Pater, H. Okkels, H. Autrup, Environmental air pollution and DNA adducts in Copenhagen bus drivers - effect of GSTM1 and NAT2 genotypes on adduct levels, Carcinogenesis 17 (1996) 1021-1027.
53. [53] P.S. Nielsen, Å. Andreassen, P.B. Farmer, S. Øvrebø, H. Autrup, Biomonitoring of diesel exhaust-exposed workers: DNA and hemoglobin adducts and urinary 1-hydroxypyrene as markers of exposure, Toxicol. Lett. 86 (1996) 27-37.
54. [54] R.A. Grinberg-Funes, V.N. Singh, F.P. Perera, D.A. Bell, T.-L. Young, C. Dickey, L.W. Wang, R.M. Santella, Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype, Carcinogenesis 15 (1994) 2449-2454.
55. [55] L.A. Mooney, D.A. Bell, R.M. Santella, A.M. van Bennekum, R. Ottman, M. Paik, W.S. Blaner, G.W. Lucier, L. Covey, T.-L. Young, T.B. Cooper, A.M. Glassman, F.P. Perera, Contribution of genetic and nutritional factors to DNA damage in heavy smokers, Carcinogenesis 18 (1997) 503-509.
56. [56] L.A. Mooney, R.M. Santella, L. Covey, A.M. Jeffrey, W. Bigbee, M.C. Randall, T.B. Cooper, R. Ottman, W.Y. Tsai, L. Wazneh, A.M. Glassman, T.-L. Young, F.P. Perera, Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 627-634.
57. [57] H. Bartsch, S. Petruzzelli, S. De Flora, E. Hietanen, A.M. Camus, M. Castegnaro, O. Geneste, A. Camoirano, R. Saracci, C. Giuntini, Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients, Mutation Res. 250 (1991) 103-114.
58. [58] H. Bartsch, M. Rojas, K. Alexandrov, A.M. Camus, M. Castegnaro, C. Malaveille, S. Anttila, K. Hirvonen, K. Husgafvel-Pursiainen, E. Hietanen, H. Vainio, Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans, Pharmacogenetics 5 (1995) 884-890.
59. [59] D. Tang, R.M. Santella, A.M. Blackwood, T.-L. Young, J. Mayer, A. Jaretzki, S. Grantham, W.Y. Tsai, F.P. Perera, A molecular epidemiological case-control study of lung cancer, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 341-346.
60. [60] H. Bartsch, DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship, Mutation Res. 340 (1996) 67-79.
61. [61] F.J. Van Schooten, F.E. van Leeuwen, M.J.X. Hillebrand, N. van Zandwijk, H.M. Jansen, L. den Engelse, E. Kriek, Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung, Carcinogenesis 13 (1992) 987-993.
62. [62] R.M. Santella, R.A. Grinberg-Funes, T.-L. Young, C. Dickey, V.N. Singh, L.W. Wang, F.P. Perera, Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells, Carcinogenesis 13 (1992) 2041-2045.
63. 32P-postlabelling assay, Carcinogenesis 12 (1991) 503-508.
64. [64] E. Grzybowska, K. Hemminki, J. Szeliga, M. Chorazy, Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes, Carcinogenesis 14 (1993) 2523-2526.
65. [65] J.K. Wiencke, K.T. Kelsey, A. Varkonyi, K. Semey, J.C. Wain, E. Mark, D.C. Christiani, Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung, Cancer Res. 55 (1995) 4910-4914.
66. [66] K. Szyfter, K. Hemminki, W. Szyfter, Z. Szmeja, J. Banaszewski, K. Yang, Aromatic DNA adducts in larynx biopsies and leukocytes, Carcinogenesis 15 (1994) 2195-2199.
67. [67] B. Binková, J. Lewtas, I. Mišková, J. Lenicek, R. Šrám, DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population, Carcinogenesis 16 (1995) 1037-1046.
68. [68] M. Rojas, K. Alexandrov, I. Cascorbi, J. Brockmöller, A. Likhachev, K. Pozharisski, G. Bouvier, G. Auburtin, L. Mayer, A. Koop-Schneider, I. Roots, H. Bartsch, High benzo[a]pyrene diol-epoxide-DNA adduct levels in lung and blood cells from subjects with combined CYP1A1 MspI/MspI-GSTM1 *0/ *0 genotypes, Pharmacogenetics 8 (1998) 109-117.
69. [69] D. Ryberg, A. Hewer, D.H. Phillips, A. Haugen, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients, Cancer Res. 54 (1994) 5801-5803.
70. [70] D. Ryberg, E. Kure, S. Lystad, V. Skaug, L. Stangeland, I. Mercy, A.-L. Børresen, A. Haugen, p53 Mutations in human lung tumors: relationship to putative susceptibility markers for cancer, Cancer Res. 54 (1994) 1551-1555.
71. [71] S. Kato, E.D. Bowman, A.M. Harrington, B. Blomeke, P.G. Shields, Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo, J. Natl. Cancer Inst. 87 (1995) 902-907.
72. 32P-postlabelling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations, Mutation Res. 368 (1996) 275-282.
73. [73] E.H. Kure, D. Ryberg, A. Hewer, D.H. Phillips, V. Skaug, R. Bæra, A. Haugen, p53 Mutations in lung tumors: relationship to gender and lung DNA adduct levels, Carcinogenesis 17 (1996) 2201-2205.
74. [74] P.G. Shields, E.D. Bowman, A.M. Harrington, V.T. Doan, A. Weston, Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes, Cancer Res. 53 (1993) 3486-3492.
75. [75] B. Schoket, D.H. Phillips, S. Kostic, I. Vincze, Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients, Carcinogenesis 19 (1998) in press.
76. [76] M. Ichiba, L. Hagmar, A. Rannug, B. Hogstedt, A.K. Alexandrie, U. Carstensen, K. Hemminki, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps, Carcinogenesis 15 (1994) 1347-1352.
77. [77] R.M. Santella, F.P. Perera, T.L. Young, Y.-J. Zhang, S. Chiamprasert, D. Tang, L.W. Wang, A. Beachman, J.-H. Lin, V.A. DeLeo, Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype, Mutation Res. 334 (1995) 117-124.
78. [78] N. Rothman, P.G. Shields, M.C. Poirier, A.M. Harrington, D.P. Ford, P.T. Strickland, The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycylic aromatic hydrocarbon-DNA adduct levels in humans, Mol. Carcinog. 14 (1995) 63-68.
79. [79] H.A. Risch, G.R. Howe, M. Jain, J.D. Burch, E.J. Holowaty, A.B. Miller, Are female smokers at higher risk for lung cancer than male smokers?, Am. J. Epidemiol. 138 (1993) 281-293.
80. [80] J.G. Stone, N.J. Jones, A.D. McGregor, R. Waters, Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa vs. biopsies, Cancer Res. 55 (1995) 1267-1270.
81. 32P-postlabelling analysis, Carcinogenesis 18 (1997) 339-344.
82. [82] T.-M. Hsu, Y.-J. Zhang, R.M. Santella, Immunoperoxidase quantitation of 4-aminobiphenyl-and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and non-smokers, Cancer Epidemiol. Biomarkers Prev. 6 (1997) 193-199.
83. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures, Mutation Res. 378 (1997) 65-75.
84. [84] J. Lewtas, D. Walsh, R. Williams, L. Dobiáš, Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses, Mutation Res. 378 (1997) 51-63.
85. [85] K. Alexandrov, M. Rojas, F.F. Kadlubar, N.P. Lang, H. Bartsch, Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa, Carcinogenesis 17 (1996) 2081-2083.
86. [86] F.J. Van Schooten, L.M. Maas, B.A. de Mol, J.C.S. Kleinjans, J.D. Durrer, Enhanced DNA damage in heart tissue of cigarette smokers, 25th Annual Meeting of the European Environmental Mutagen Society, Noordwijkerhout, The Netherlands, Abstract 4.37 (1996) 159.
87. [87] A. Izzotti, S. DeFlora, G.L. Petrilli, J. Gallagher, M. Rojas, K. Alexandrov, H. Bartsch, J. Lewtas, Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 105-110.
88. [88] D.H. Li, M. Wang, K. Dhingra, W.N. Hittelman, Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology, Cancer Res. 56 (1996) 287-293.
89. [89] M. Degawa, S.T. Stern, M.V. Martin, P. Guengerich, P.P. Fu, K.F. Ilett, R.K. Kaderlik, F.F. Kadlubar, Metabolic activation and carcinogen-DNA adduct detection in human larynx, Cancer Res. 54 (1994) 4915-4919.